Sherry Liu
About
Sherry Liu is a scholar working on Psychiatry and Mental health, Molecular Biology and Surgery.
According to data from OpenAlex, Sherry Liu has authored 29 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Sherry Liu's work include Schizophrenia research and treatment (7 papers), Bipolar Disorder and Treatment (6 papers) and Child and Adolescent Psychosocial and Emotional Development (4 papers). Sherry Liu is often cited by papers focused on Schizophrenia research and treatment (7 papers), Bipolar Disorder and Treatment (6 papers) and Child and Adolescent Psychosocial and Emotional Development (4 papers). Sherry Liu collaborates with scholars based in United States, United Kingdom and Sweden. Sherry Liu's co-authors include Björn Paulsson, Trisha Suppes, Eduard Vieta, Hans Eriksson, Martin Brecher, Barry M. Zee, Antti Ahokas, Ivan Eggens, Willie Earley and Robert L. Findling and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.
In The Last Decade
Sherry Liu
25 papers receiving 716 citations
Peers
Sherry Liu
Tzu‐Ting Chen Taiwan
Wen Xu United States
Frank Rouby France
Raj Mehta United Kingdom
Charles Richardson United States
David Stamler United States
Joseph J. Rasimas United States
Marta Casillas Spain
Patrick Martin United States
Susan Edwards United Kingdom
Citations per year, relative to Sherry Liu Sherry Liu (= 1×)
peers
Tzu‐Ting Chen
Countries citing papers authored by Sherry Liu
Since
Specialization
Citations
This map shows the geographic impact of Sherry Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Liu more than expected).
Fields of papers citing papers by Sherry Liu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Sherry Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Liu. The network helps show where Sherry Liu may publish in the future.
Co-authorship network of co-authors of Sherry Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Sherry Liu. A scholar is included among the top collaborators of Sherry Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry Liu. Sherry Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bourne, Christopher M., Madhura Kulkarni, Sherry Liu, et al.. (2025). A Potent Inhibitor of Caspase-8 Based on the IL-18 Tetrapeptide Sequence Reveals Shared Specificities between Inflammatory and Apoptotic Initiator Caspases. PubMed. 5(4). 565–581.
2.
Clarke, Noel W., Andrew J. Armstrong, Antoine Thiery-Vuillemin, et al.. (2019). PROPEL: A randomized, phase III trial evaluating the efficacy and safety of olaparib combined with abiraterone as first-line therapy in patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 37(7_suppl). TPS340–TPS340.
3.
Wang, Baoguang, Sherry Liu, & Alexander Persoskie. (2019). Poisoning exposure cases involving e-cigarettes and e-liquid in the United States, 2010–2018. Clinical Toxicology. 58(6). 488–494.
4.
Reesink, Heidi L., Alan J. Nixon, Jin Su, et al.. (2018). Galectins-1 and-3 Increase in Equine Post-traumatic Osteoarthritis. Frontiers in Veterinary Science. 5. 288–288.
5.
Bono, Johann S. de, Maha Hussain, Antoine Thiery-Vuillemin, et al.. (2017). PROfound: A randomized Phase III trial evaluating olaparib in patients with metastatic castration-resistant prostate cancer and a deleterious homologous recombination DNA repair aberration.. Journal of Clinical Oncology. 35(15_suppl). TPS5091–TPS5091.
6.
Meng, Min, et al.. (2016). Simultaneous quantitation of polymyxin B1, polymyxin B2 and polymyxin B1-1 in human plasma and treated human urine using solid phase extraction and liquid chromatography–tandem mass spectrometry. Journal of Chromatography B. 1012-1013. 23–36.
7.
Reesink, Heidi L., Edward D. Bonnevie, Sherry Liu, et al.. (2016). Galectin-3 Binds to Lubricin and Reinforces the Lubricating Boundary Layer of Articular Cartilage. Scientific Reports. 6(1). 25463–25463.
8.
Thompson, Laura, Sherry Liu, Hong Lü, et al.. (2016). Adaptive Design Practice at the Center for Devices and Radiological Health (CDRH), January 2007 to May 2013. Therapeutic Innovation & Regulatory Science. 50(6). 710–717.
9.
Findling, Robert L., Sanjeev Pathak, Willie Earley, Sherry Liu, & Melissa P. DelBello. (2014). Efficacy and Safety of Extended-Release Quetiapine Fumarate in Youth with Bipolar Depression: An 8 Week, Double-Blind, Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 24(6). 325–335.
10.
Bauer, Michael, Michael E. Thase, Sherry Liu, Willie Earley, & Hans Eriksson. (2014). Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder. Journal of Psychopharmacology. 29(5). 565–574.
11.
Findling, Robert L., Sanjeev Pathak, Willie Earley, Sherry Liu, & Melissa P. DelBello. (2013). Safety, Tolerability, and Efficacy of Quetiapine in Youth with Schizophrenia or Bipolar I Disorder: A 26-Week, Open-Label, Continuation Study. Journal of Child and Adolescent Psychopharmacology. 23(7). 490–501.
12.
LeRoy, Gary, Peter A. DiMaggio, Eric Y. Chan, et al.. (2013). A quantitative atlas of histone modification signatures from human cancer cells. Epigenetics & Chromatin. 6(1). 20–20.
13.
Gotto, Antonio M., Christopher P. Cannon, Sukrut Shah, et al.. (2011). Abstract 15035: Effects on Lipids and Safety Following Cessation of Treatment with Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients with or at High Risk for Coronary Heart Disease. Circulation. 124(10). 3673–81.
14.
Dansky, Hayes M., Daniel M. Bloomfield, Patrice H. Gibbons, et al.. (2011). Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia. American Heart Journal. 162(4). 708–716.
15.
Katzman, Martin A., et al.. (2010). Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder. International Clinical Psychopharmacology. 26(1). 11–24.
16.
Paulsson, Björn, et al.. (2009). Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: Results of a markov model analysis. Clinical Therapeutics. 31. 1456–1468.
17.
Suppes, Trisha, et al.. (2009). Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study of Quetiapine in Combination With Lithium or Divalproex (Trial 127). American Journal of Psychiatry. 166(4). 476–488.
18.
Bandelow, Borwin, Guy Chouinard, Julio Bobes, et al.. (2009). Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. The International Journal of Neuropsychopharmacology. 13(3). 305–305.
19.
Miner, Philip B., Radu Țuțuian, Donald O. Castell, Sherry Liu, & Mark Sostek. (2006). Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: An open-label crossover study in healthy adult volunteers. Clinical Therapeutics. 28(5). 725–733.
20.
DeVault, Kenneth R., John F. Johanson, David A. Johnson, Sherry Liu, & Mark Sostek. (2006). Maintenance of Healed Erosive Esophagitis: A Randomized Six-Month Comparison of Esomeprazole Twenty Milligrams With Lansoprazole Fifteen Milligrams. Clinical Gastroenterology and Hepatology. 4(7). 852–859.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Tzu‐Ting Chen Breakdown of academic impact, for papers by Wen Xu Breakdown of academic impact, for papers by Frank Rouby Breakdown of academic impact, for papers by Raj Mehta Breakdown of academic impact, for papers by Charles Richardson Breakdown of academic impact, for papers by David Stamler Breakdown of academic impact, for papers by Joseph J. Rasimas Breakdown of academic impact, for papers by Marta Casillas Breakdown of academic impact, for papers by Patrick Martin Breakdown of academic impact, for papers by Susan Edwards